Tandem Diabetes Care Stock Widgets and Gadgets
TNDM Stock | USD 31.73 1.30 4.27% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- TNDM Tandem Diabetes Care
- Latest Tandem Diabetes Care Upgraded to Hold at StockNews.com - Defense World
- TNDM 31.73 1.3
- Low 30.12
- High 31.92
- Volume 1.2 M
- Alpha 0.29
- Beta 2.26
- Return On Equity -0.59
- Return On Asset -0.0963
- Profit Margin (0.30) %
- Operating Margin (0.18) %
- Current Valuation 1.95 B
- Shares Outstanding 64.56 M
- Shares Owned By Insiders 0.60 %
- Shares Owned By Institutions 99.40 %
- Number Of Shares Shorted 9.31 M
- Price To Earning 494.25 X
- Price To Book 6.90 X
- Price To Sales 2.89 X
- Revenue 747.72 M
- Gross Profit 412.99 M
- EBITDA (118.22 M)
- Net Income (222.61 M)
- Cash And Equivalents 608.73 M
- Cash Per Share 9.47 X
- Total Debt 415.67 M
- Debt To Equity 1.00 %
- Current Ratio 4.80 X
- Book Value Per Share 4.78 X
- Cash Flow From Operations (31.81 M)
- Short Ratio 4.00 X
- Earnings Per Share (3.43) X
- Target Price 35.93
- Number Of Employees 2.4 K
- Beta 1.13
- Market Capitalization 1.96 B
- Total Asset 952.66 M
- Retained Earnings (951.8 M)
- Working Capital 552.73 M
- Current Asset 106.98 M
- Current Liabilities 26.52 M
- Net Asset 952.66 M
- Accumulation Distribution 69381.82
- Daily Balance Of Power 0.7222
- Rate Of Daily Change 1.04
- Day Median Price 31.02
- Day Typical Price 31.26
- Price Action Indicator 1.36
- Period Momentum Indicator 1.3
Market Snapshot Widget Example
DAX Index Germany | 17,861 0.70 | |
Taiwan Weighted Taiwan | 19,411 0.59 | |
PSI 20 Stock Portugal | 6,515 3.50 | |
CROBEX Croatia | 2,803 0.14 | |
Budapest SE Hungary | 65,126 0.12 | |
IDX 30 Jakarta Indonesia | 467.48 0.14 | |
ISEQ 20 Price Ireland | 1,646 0.05 | |
NYSE Comp USA | 17,602 0.82 | |
Tel Aviv 35 Israel | 1,912 1.29 | |
Coreshares Index Tracker South Afric | 1,026 0.59 | |
IPC MEXICO Mexico | 56,552 1.23 | |
KL Technology Malaysia | 62.69 0.14 | |
IBEX 35 Index Spain | 10,890 1.50 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,554 0.49 | |
SPASX Dividend Opportunities Australia | 1,655 0.68 | |
HNX 30 Vietnam | 481.21 2.96 | |
Bucharest BET-NG Romania | 1,205 0.11 | |
AMS Small Cap Netherlands | 1,189 0.52 | |
Oslo Exchange Mutual Norway | 1,290 0.01 | |
BEL Small Belgium | 9,020 1.28 | |
RTSI Index Russia | 1,173 0.06 | |
Basic Materials Brazil | 5,966 0.05 | |
Swiss Leader Price Switzerland | 1,847 0.38 | |
Fondo Mutuo ETF Chile | 1,407 0.21 | |
Athens General Comp Greece | 1,420 1.99 | |
Stock Exchange Of Thailand | 1,350 1.31 | |
PX Prague Stock Czech Repub | 1,551 0.02 | |
THE PHILIPPINE STOCK Philippines | 6,444 0.02 | |
WIG 30 Poland | 3,102 1.72 | |
BIST Electricity Turkey | 595.36 0.54 |
Investing Ideas
In addition to having Tandem Diabetes in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Tandem Diabetes
Compare Tandem Diabetes To Peers
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Tandem Diabetes Care information on this page should be used as a complementary analysis to other Tandem Diabetes' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Tandem Stock analysis
When running Tandem Diabetes' price analysis, check to measure Tandem Diabetes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tandem Diabetes is operating at the current time. Most of Tandem Diabetes' value examination focuses on studying past and present price action to predict the probability of Tandem Diabetes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tandem Diabetes' price. Additionally, you may evaluate how the addition of Tandem Diabetes to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Tandem Diabetes' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.37) | Earnings Share (3.43) | Revenue Per Share 11.509 | Quarterly Revenue Growth (0.11) | Return On Assets (0.1) |
The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.